These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 12773477)

  • 1. Modulation of prion protein structural integrity by geldanamycin.
    Ochel HJ; Gademann G; Trepel J; Neckers L
    Glycobiology; 2003 Sep; 13(9):655-60. PubMed ID: 12773477
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antibiotic radicicol binds to the N-terminal domain of Hsp90 and shares important biologic activities with geldanamycin.
    Schulte TW; Akinaga S; Soga S; Sullivan W; Stensgard B; Toft D; Neckers LM
    Cell Stress Chaperones; 1998 Jun; 3(2):100-8. PubMed ID: 9672245
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Structural basis for inhibition of the Hsp90 molecular chaperone by the antitumor antibiotics radicicol and geldanamycin.
    Roe SM; Prodromou C; O'Brien R; Ladbury JE; Piper PW; Pearl LH
    J Med Chem; 1999 Jan; 42(2):260-6. PubMed ID: 9925731
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interaction of radicicol with members of the heat shock protein 90 family of molecular chaperones.
    Schulte TW; Akinaga S; Murakata T; Agatsuma T; Sugimoto S; Nakano H; Lee YS; Simen BB; Argon Y; Felts S; Toft DO; Neckers LM; Sharma SV
    Mol Endocrinol; 1999 Sep; 13(9):1435-48. PubMed ID: 10478836
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Destabilization of the non-pathogenic, cellular prion-protein by a small molecular drug.
    Ochel HJ; Gademann G
    Antivir Ther; 2004 Jun; 9(3):441-5. PubMed ID: 15259907
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synergistic inhibition of the glucocorticoid receptor by radicicol and benzoquinone ansamycins.
    Rosenhagen MC; Young JC; Wochnik GM; Herr AS; Schmidt U; Hartl FU; Holsboer F; Rein T
    Biol Chem; 2001 Mar; 382(3):499-504. PubMed ID: 11347901
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Involvement of calcium in the differential induction of heat shock protein 70 by heat shock protein 90 inhibitors, geldanamycin and radicicol, in human non-small cell lung cancer H460 cells.
    Chang YS; Lee LC; Sun FC; Chao CC; Fu HW; Lai YK
    J Cell Biochem; 2006 Jan; 97(1):156-65. PubMed ID: 16173045
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Requirement of Hsp90 activity for IkappaB kinase (IKK) biosynthesis and for constitutive and inducible IKK and NF-kappaB activation.
    Broemer M; Krappmann D; Scheidereit C
    Oncogene; 2004 Jul; 23(31):5378-86. PubMed ID: 15077173
    [TBL] [Abstract][Full Text] [Related]  

  • 9. KF25706, a novel oxime derivative of radicicol, exhibits in vivo antitumor activity via selective depletion of Hsp90 binding signaling molecules.
    Soga S; Neckers LM; Schulte TW; Shiotsu Y; Akasaka K; Narumi H; Agatsuma T; Ikuina Y; Murakata C; Tamaoki T; Akinaga S
    Cancer Res; 1999 Jun; 59(12):2931-8. PubMed ID: 10383157
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hsp90 inhibition accelerates cell lysis. Anti-Hsp90 ribozyme reveals a complex mechanism of Hsp90 inhibitors involving both superoxide- and Hsp90-dependent events.
    Sreedhar AS; Mihály K; Pató B; Schnaider T; Steták A; Kis-Petik K; Fidy J; Simonics T; Maraz A; Csermely P
    J Biol Chem; 2003 Sep; 278(37):35231-40. PubMed ID: 12842893
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Geldanamycin derivative inhibition of HGF/SF-mediated Met tyrosine kinase receptor-dependent urokinase-plasminogen activation.
    Shen Y; Xie Q; Norberg M; Sausville E; Vande Woude G; Wenkert D
    Bioorg Med Chem; 2005 Aug; 13(16):4960-71. PubMed ID: 15978816
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Design, synthesis, and evaluation of a radicicol and geldanamycin chimera, radamide.
    Clevenger RC; Blagg BS
    Org Lett; 2004 Nov; 6(24):4459-62. PubMed ID: 15548050
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Radanamycin, a macrocyclic chimera of radicicol and geldanamycin.
    Wang M; Shen G; Blagg BS
    Bioorg Med Chem Lett; 2006 May; 16(9):2459-62. PubMed ID: 16464590
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hsp90 chaperones wild-type p53 tumor suppressor protein.
    Walerych D; Kudla G; Gutkowska M; Wawrzynow B; Muller L; King FW; Helwak A; Boros J; Zylicz A; Zylicz M
    J Biol Chem; 2004 Nov; 279(47):48836-45. PubMed ID: 15358769
    [TBL] [Abstract][Full Text] [Related]  

  • 15. hsp90 is required for heme binding and activation of apo-neuronal nitric-oxide synthase: geldanamycin-mediated oxidant generation is unrelated to any action of hsp90.
    Billecke SS; Bender AT; Kanelakis KC; Murphy PJ; Lowe ER; Kamada Y; Pratt WB; Osawa Y
    J Biol Chem; 2002 Jun; 277(23):20504-9. PubMed ID: 11923316
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hsp90 inhibitors attenuate effect of dexamethasone on activated NF-kappaB and AP-1.
    Tago K; Tsukahara F; Naruse M; Yoshioka T; Takano K
    Life Sci; 2004 Mar; 74(16):1981-92. PubMed ID: 14967193
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Geldanamycin-associated inhibition of intracellular trafficking is attributed to a co-purified activity.
    Barzilay E; Ben-Califa N; Supino-Rosin L; Kashman Y; Hirschberg K; Elazar Z; Neumann D
    J Biol Chem; 2004 Feb; 279(8):6847-52. PubMed ID: 14660597
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Targeting of the protein chaperone, HSP90, by the transformation suppressing agent, radicicol.
    Sharma SV; Agatsuma T; Nakano H
    Oncogene; 1998 May; 16(20):2639-45. PubMed ID: 9632140
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The topoisomerase II-Hsp90 complex: a new chemotherapeutic target?
    Barker CR; Hamlett J; Pennington SR; Burrows F; Lundgren K; Lough R; Watson AJ; Jenkins JR
    Int J Cancer; 2006 Jun; 118(11):2685-93. PubMed ID: 16385570
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of geldanamycin on the kinetics of chaperone-mediated renaturation of firefly luciferase in rabbit reticulocyte lysate.
    Thulasiraman V; Matts RL
    Biochemistry; 1996 Oct; 35(41):13443-50. PubMed ID: 8873613
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.